Edesa Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Edesa Biotech and other ETFs, options, and stocks.About EDSA
Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo.
CEOPardeep Nijhawan
CEOPardeep Nijhawan
Employees16
Employees16
HeadquartersMarkham, Ontario
HeadquartersMarkham, Ontario
Founded2007
Founded2007
Employees16
Employees16
EDSA Key Statistics
Market cap16.85M
Market cap16.85M
Price-Earnings ratio-1.48
Price-Earnings ratio-1.48
Dividend yield—
Dividend yield—
Average volume46.19K
Average volume46.19K
High today$2.58
High today$2.58
Low today$2.34
Low today$2.34
Open price$2.54
Open price$2.54
Volume19.64K
Volume19.64K
52 Week high$5.59
52 Week high$5.59
52 Week low$1.55
52 Week low$1.55
People also own
Based on the portfolios of people who own EDSA. This list is generated using Robinhood data, and it’s not a recommendation.